Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models

Mammalian Target of Rapamycin complex 2 (mTORC2) and its regulatory component Rapamycin-insensitive companion of mTOR (RICTOR) are increasingly recognized as important players in human cancer development and progression. However, the role of RICTOR in human pancreatic ductal adenocarcinoma (PDAC) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Katharina M., Hellerbrand, Claus, Ruemmele, Petra, Michalski, Christoph W., Kong, Bo, Kroemer, Alexander, Hackl, Christina, Schlitt, Hans J., Geissler, Edward K., Lang, Sven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421865/
https://www.ncbi.nlm.nih.gov/pubmed/28445935
http://dx.doi.org/10.18632/oncotarget.15524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421865/
https://www.ncbi.nlm.nih.gov/pubmed/28445935
http://dx.doi.org/10.18632/oncotarget.15524

Ejemplares similares